July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Phenylboronic Acid Based Mucoadhesive Polymeric Micelles for Anterior Drug Delivery
Author Affiliations & Notes
  • Jennifer Jing Yuan Tian
    Chemical Engineering , McMaster , Hamilton, Ontario, Canada
  • Heather Sheardown
    Chemical Engineering , McMaster , Hamilton, Ontario, Canada
  • Naveed Yasin
    Chemical Engineering , McMaster , Hamilton, Ontario, Canada
  • Talena Rambarran
    Chemical Engineering , McMaster , Hamilton, Ontario, Canada
  • Lina Liu
    Chemical Engineering , McMaster , Hamilton, Ontario, Canada
  • Footnotes
    Commercial Relationships   Jennifer Tian, None; Heather Sheardown, None; Naveed Yasin, None; Talena Rambarran, None; Lina Liu, None
  • Footnotes
    Support  Ontario Research Fund (C20/20: Responsive Materials for Ocular Therapy)
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 3375. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jennifer Jing Yuan Tian, Heather Sheardown, Naveed Yasin, Talena Rambarran, Lina Liu; Phenylboronic Acid Based Mucoadhesive Polymeric Micelles for Anterior Drug Delivery. Invest. Ophthalmol. Vis. Sci. 2019;60(9):3375.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Conventional anterior drug delivery methods are ineffective due to the low bioavailability caused by static and dynamic barriers which result in rapid drug clearance. Due to the longer clearance time of mucins compared with tears, we hypothesize that Phenylboronic Acid (PBA), a known mucoadhesive, based micelles can enhance drug delivery to the anterior eye. PBA based micelles can increase retention time, bioavailability, and can be used with a wide array of drugs.

Methods : Poly(L-lactide)-b-poly(methacrylic acid-co-3-acrylamidophenylboronic acid) block copolymer micelles previously developed in the Sheardown lab were synthesized by free radical polymerization. Nuclear magnetic resonance (NMR) was used to confirm structure and molecular weight. Drug release studies were completed with micelles loaded with high (0.75 μg/mL) and low dose (0.50 μg/mL) of Cyclosporine A (CycA) in dialysis tubing released into simulated tear fluid, changed at regular intervals over a two-week period. Drug was detected via high-performance liquid chromatography (HPLC). Micelles were further dissolved and contents were removed to measure remaining drug concentration. Timolol, Latanoprost, Atropine, Dexamethasone, and Clarithromycin were tested for compatibility based on logP values and their entrapment efficiencies were determined using HPLC.

Results : NMR showed similarities between the micelles tested and those previously synthesized in terms of structure and molecular weight. Micelles showed the capability of sequestering 50% more drug compared to Restasis with preliminary studies showing loading capabilities beyond 1.00 μg/mL. Figure 1 shows a sustained CycA release with no initial burst compared to the control. The drug release profile follows pseudo-zero-order kinetics up until day 6, where all the drug has been released and the remaining drug is cleared with the micelles. The study on entrapment efficiencies showed that a drug with a logP value of 1.28 displayed poor entrapment efficiency (3.7 ± 2.9%) while drugs with logP values of 2.79 and 4.28 showed good entrapment efficiencies of 69.3 ± 1.3% and 23.7 ± 1.2% respectively.

Conclusions : Anterior drug delivery methods can be improved by using PBA based micelles due to their ability to produce a sustained release as well as improve bioavailability through increased drug residence time.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

 

Figure 1: Drug release profile for high and low dose Cyclosporine A compared with control.

Figure 1: Drug release profile for high and low dose Cyclosporine A compared with control.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×